Navigation Links
Vanda Pharmaceuticals' VSF-173 Excessive Sleepiness Phase II Clinical Trial Suggests Wake-Promoting Properties
Date:10/30/2007

ed improvements of 2.1, 3.4 and 2.1 minutes, respectively, compared to placebo. For the dose group of 100 mg, this observation of improvement was statistically significant (p < 0.05).

Further evidence of the wake-promoting properties of VSF-173 was also observed during the scheduled daytime recovery sleep following the night time and morning evaluations. Statistically significant (p<.05; non-parametric) dose-dependent correlations were observed with the following polysomnography (PSG) parameters: increased number of awakenings, decreased sleep efficiency and total sleep time for the first third of the sleep period, and increased wake time after sleep onset for the first 3 hours of the sleep period.

These wake-promoting effects of VSF-173 on MWT and PSG measures suggest that VSF-173 possesses a novel mechanism to address disorders of excessive sleepiness. Vanda plans to conduct additional studies to further understand timing of administration, dose-response and appropriate populations to treat. VSF-173 was also demonstrated to be safe and well-tolerated.

"We are encouraged by the results of this proof-of-concept study on VSF-173," stated Mihael Polymeropoulos, M.D., President and CEO of Vanda. "We believe that the compound has the potential to address the symptoms of excessive sleepiness in the context of a number of disorders including narcolepsy and shift worker sleep disorder, as well as neurodegenerative disorders."

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company with a particular focus on the development and commercialization of clinical-stage product candidates for central nervous system disorders. The company has three product candidates in clinical development. In addition to VSF-173, Vanda is developing Iloperidone, a drug for schizophrenia, which has recently been submitted for marketing approval to the FDA, and VEC-162, a compound for the treatment of sleep and mood disorders, which h
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... one day lead to a novel technique to combat cance...ealthDay News) -- Belgian researchers have discove... of sugar for food, and this might lead to new tre...survive and proliferate, all cells in the body nee... [glucose], a process that requires oxygen. Compar...
(Date:11/21/2008)... Nov. 21 NursingCenter.com, the pr...n and peer reviewed content, has been,updated to ... registered,users. Powered by Lippincott Williams...des over 900 peer-reviewed continuing education ac...more than 50 leading nursing journals.,Lippincott...
(Date:11/21/2008).... 21 The general membership of the... three new individuals at their Annual,Awards Din...el in New York. A,Lifetime Achievement Award will...he Medical Advertising Hall of Fame are: , Rona... an account position,at Sudler & Hennessey. I...
(Date:11/21/2008)... popular drugs do not cause genetic damage that ca...ealthDay News) -- Two popular medications for trea...D) do not cause genetic damage linked to an increa..., The study, done by researchers at Duke Univer... Health, counters a previous one that reported bio...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2
...as found that a breakdown of myelin is associated ... Last month, Dr. George Bartzokis, director of the...nic, suggested in the journal Alzheimer's and De... develops late in life promotes the enlargement of...
...fied in Electropathy, an alternative system of med...t of their demand for jobs in state-run hospitals...ectricity. The doctors, who have been staging pr...ver two months, complain that the authorities have...
...lth Organization (WHO) today released the first ev...environmental factors have on health, and it revea...vented every year by making environments healthier...s but also demonstrate that in every country, peop...
...found new evidence that supports the link between ...ted to smallpox vaccination . Immunization with l...s sometimes found to cause reactions that range fr...illness. The study was conducted by a team of res...
Other Medicine News:Health News:Myelin Associated With Early Evolution of Huntington's Disease 2Health News:Myelin Associated With Early Evolution of Huntington's Disease 3Health News:13 Million Die Worldwide Due to Unhealthy Environment: New WHO Report 2Health News:New Evidence Links Smallpox Vaccination Side Effects to Genetic Factors 2
(Date:11/19/2008)...9 Posit Science Corporation,resea...ty for Neuroscience,Annual Conference in Washingt...ng may benefit Baby Boomers. The computerized bra...es adaptive exercises that target auditory and,la...ve generalized,improvements in cognition by impro...
(Date:11/19/2008)... not achieve statistical significance , , I...armos Corporation (Nasdaq: PARS ) today announce...topical NanoEmulsion (NE) drug delivery technology... , The multi-center, randomized, double-blind...and efficacy of the Company,s 3% Diclofenac Dietha...
(Date:11/19/2008)...ov. 19 Biotech scientists increasi...ogy research to better understand the effects of n..., reports Genetic Engineering & Biotechnology...figuring out a new compound,s mechanism of action ...technique, according to the November 15 issue of ...
(Date:11/19/2008)...Payment from Roche- , , MONTVALE, N.J., Nov...als Corp. (Nasdaq: MEMY ) today announced that i... trial of R3487/MEM 3454, its lead alpha-7 nicotin...iated with schizophrenia (CIAS). The Company has ...gering a $5.0 million payment from its partner Roc...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 1Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 2Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 3Agfa HealthCare InterComponentWare and Sun Microsystems Join Open eHealth Foundation at HIMSS08 12755 4Web Tool Aids Men in Prostate Decisions 12753 1Web Tool Aids Men in Prostate Decisions 12753 2Social Security Lifts 1 3 Million Children Out of Poverty 12751 1Social Security Lifts 1 3 Million Children Out of Poverty 12751 2Five Years of VA Health Care for Combat Veterans 12749 1Five Years of VA Health Care for Combat Veterans 12749 2
Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: